When viewed as the ratio of the 50 kDa fragment to the mature fibulin-1 polypeptide, fibulin-1 processing was more extensive in ERα-positive as compared to ERα-negative breast carcinomas (P < 0.05, n=36) (Figures 2 and 4). This evidence concerns the gene FBLN1 and breast carcinoma.